TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 133 filers reported holding TG THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $494,562 | +14.4% | 27,800 | -2.2% | 0.00% | 0.0% |
| Q1 2024 | $432,375 | -25.0% | 28,427 | -15.8% | 0.00% | 0.0% |
| Q4 2023 | $576,313 | +161.0% | 33,742 | +27.8% | 0.00% | +100.0% |
| Q3 2023 | $220,804 | -62.3% | 26,412 | +11.9% | 0.00% | -66.7% |
| Q2 2023 | $586,398 | +74.4% | 23,607 | +5.6% | 0.00% | +50.0% |
| Q1 2023 | $336,234 | +27.1% | 22,356 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $264,471 | +147.2% | 22,356 | +23.8% | 0.00% | 0.0% |
| Q3 2022 | $107,000 | +39.0% | 18,059 | 0.0% | 0.00% | – |
| Q2 2022 | $77,000 | -55.2% | 18,059 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $172,000 | -40.7% | 18,059 | +18.3% | 0.00% | 0.0% |
| Q4 2021 | $290,000 | -20.5% | 15,264 | +39.0% | 0.00% | -50.0% |
| Q3 2021 | $365,000 | -14.3% | 10,978 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $426,000 | -19.5% | 10,978 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $529,000 | -16.4% | 10,978 | -9.8% | 0.00% | -25.0% |
| Q4 2020 | $633,000 | +110.3% | 12,164 | +8.2% | 0.00% | +100.0% |
| Q3 2020 | $301,000 | +95.5% | 11,238 | +41.7% | 0.00% | +100.0% |
| Q2 2020 | $154,000 | +161.0% | 7,929 | +31.4% | 0.00% | 0.0% |
| Q1 2020 | $59,000 | +20.4% | 6,032 | +37.5% | 0.00% | – |
| Q4 2019 | $49,000 | +96.0% | 4,387 | 0.0% | 0.00% | – |
| Q3 2019 | $25,000 | -34.2% | 4,387 | 0.0% | 0.00% | – |
| Q2 2019 | $38,000 | +8.6% | 4,387 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | +94.4% | 4,387 | 0.0% | 0.00% | – |
| Q4 2018 | $18,000 | -28.0% | 4,387 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | -56.9% | 4,387 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $58,000 | -6.5% | 4,387 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $62,000 | +244.4% | 4,387 | +94.5% | 0.00% | – |
| Q4 2017 | $18,000 | -33.3% | 2,255 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | +17.4% | 2,255 | 0.0% | 0.00% | – |
| Q2 2017 | $23,000 | -11.5% | 2,255 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +160.0% | 2,255 | 0.0% | 0.00% | – |
| Q4 2016 | $10,000 | -41.2% | 2,255 | 0.0% | 0.00% | – |
| Q3 2016 | $17,000 | +21.4% | 2,255 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | -26.3% | 2,255 | 0.0% | 0.00% | – |
| Q1 2016 | $19,000 | -29.6% | 2,255 | 0.0% | 0.00% | – |
| Q4 2015 | $27,000 | +350.0% | 2,255 | +307.8% | 0.00% | – |
| Q3 2015 | $6,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 10,451,241 | $157,186,665 | 42.99% |
| M28 Capital Management LP | 339,500 | $5,106,080 | 5.77% |
| Ghost Tree Capital, LLC | 1,100,000 | $16,544,000 | 4.89% |
| Soleus Capital Management, L.P. | 750,300 | $11,284,512 | 1.17% |
| Parkman Healthcare Partners LLC | 275,641 | $4,145,641 | 0.90% |
| 683 Capital Management, LLC | 775,000 | $11,656,000 | 0.87% |
| Leucadia National | 5,100,110 | $76,705,654 | 0.62% |
| Pier Capital, LLC | 233,472 | $3,511,419 | 0.53% |
| Harvest Investment Services, LLC | 40,729 | $612,564 | 0.47% |
| Artal Group S.A. | 511,389 | $7,691 | 0.46% |